Macular ischemia and outcome of vitrectomy for diabetic macular edema

详细信息    查看全文

• 作者：Jaeryung Kim ; Se Woong Kang ; Dong Hoon Shin…
• 关键词：Macular ischemia ; Diabetic macular edema ; Foveal avascular zone ; Pars plana vitrectomy
• 刊名：Japanese Journal of Ophthalmology
• 出版年：2015
• 出版时间：September 2015
• 年：2015
• 卷：59
• 期：5
• 页码：295-304
• 全文大小：756 KB
• 参考文献：1.Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35:556鈥?4.CrossRef PubMed Central PubMed
  2.Photocoagulation for diabetic macular edema. Early treatment diabetic retinopathy study report number 1. early treatment diabetic retinopathy study research group. Arch Ophthalmol. 1985;103:1796鈥?06.CrossRef
  3.Massin P, Audren F, Haouchine B, Erginay A, Bergmann JF, Benosman R, et al. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial. Ophthalmology. 2004;111:218鈥?4 (discussion 24鈥?).CrossRef PubMed
  4.Entezari M, Ahmadieh H, Dehghan MH, Ramezani A, Bassirnia N, Anissian A. Posterior sub-tenon triamcinolone for refractory diabetic macular edema: a randomized clinical trial. Eur J Ophthalmol. 2005;15:746鈥?0.PubMed
  5.Massin P, Bandello F, Garweg JG, Hansen LL, Harding SP, Larsen M, et al. Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE study): a 12-month, randomized, controlled, double-masked, multicenter phase II study. Diabetes Care. 2010;33:2399鈥?05.CrossRef PubMed Central PubMed
  6.Arevalo JF, Sanchez JG, Wu L, Maia M, Alezzandrini AA, Brito M, et al. Primary intravitreal bevacizumab for diffuse diabetic macular edema: the Pan-American collaborative retina study group at 24聽months. Ophthalmology. 2009;116:1488鈥?7 (97 e1).CrossRef PubMed
  7.Kang SW, Sa HS, Cho HY, Kim JI. Macular grid photocoagulation after intravitreal triamcinolone acetonide for diffuse diabetic macular edema. Arch Ophthalmol. 2006;124:653鈥?.CrossRef PubMed
  8.Elman MJ, Bressler NM, Qin H, Beck RW, Ferris FL 3rd, Friedman SM, et al. Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology. 2011;118:609鈥?4.CrossRef PubMed Central PubMed
  9.Ho AC, Scott IU, Kim SJ, Brown GC, Brown MM, Ip MS, et al. Anti-vascular endothelial growth factor pharmacotherapy for diabetic macular edema: a report by the American Academy of Ophthalmology. Ophthalmology. 2012;119:2179鈥?8.CrossRef PubMed
  10.Figueroa MS, Contreras I, Noval S. Surgical and anatomical outcomes of pars plana vitrectomy for diffuse nontractional diabetic macular edema. Retina. 2008;28:420鈥?.CrossRef PubMed
  11.Recchia FM, Ruby AJ. Carvalho Recchia CA. Pars plana vitrectomy with removal of the internal limiting membrane in the treatment of persistent diabetic macular edema. Am J Ophthalmol. 2005;139:447鈥?4.CrossRef PubMed
  12.Stolba U, Binder S, Gruber D, Krebs I, Aggermann T, Neumaier B. Vitrectomy for persistent diffuse diabetic macular edema. Am J Ophthalmol. 2005;140:295鈥?01.CrossRef PubMed
  13.Kang SW, Park SC, Cho HY, Kang JH. Triple therapy of vitrectomy, intravitreal triamcinolone, and macular laser photocoagulation for intractable diabetic macular edema. Am J Ophthalmol. 2007;144:878鈥?5.CrossRef PubMed
  14.Kim YT, Kang SW, Kim SJ, Kim SM, Chung SE. Combination of vitrectomy, IVTA, and laser photocoagulation for diabetic macular edema unresponsive to prior treatments: 3-year results. Graefes Arch Clin Exp Ophthalmol. 2012;250:679鈥?4.CrossRef PubMed
  15.Kumagai K, Furukawa M, Ogino N, Larson E, Iwaki M, Tachi N. Long-term follow-up of vitrectomy for diffuse nontractional diabetic macular edema. Retina. 2009;29:464鈥?2.CrossRef PubMed
  16.Saeed AM. Combined vitrectomy and intravitreal injection versus combined laser and injection for treatment of intractable diffuse diabetic macular edema. Clin Ophthalmol. 2013;7:283鈥?7.CrossRef PubMed Central PubMed
  17.Chhablani JK, Kim JS, Cheng LY, Kozak I, Freeman W. External limiting membrane as a predictor of visual improvement in diabetic macular edema after pars plana vitrectomy. Graefes Arch Clin Exp Ophthalmol. 2012;250:1415鈥?0.CrossRef PubMed
  18.Yamamoto T, Hitani K, Tsukahara I, Yamamoto S, Kawasaki R, Yamashita H, et al. Early postoperative retinal thickness changes and complications after vitrectomy for diabetic macular edema. Am J Ophthalmol. 2003;135:14鈥?.CrossRef PubMed
  19.Haller JA, Qin H, Apte RS, Beck RR, Bressler NM, Browning DJ, et al. Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction. Ophthalmology. 2010;117(1087鈥?3):e3.
  20.Flaxel CJ, Edwards AR, Aiello LP, Arrigg PG, Beck RW, Bressler NM, et al. Factors associated with visual acuity outcomes after vitrectomy for diabetic macular edema: diabetic retinopathy clinical research network. Retina. 2010;30:1488鈥?5.CrossRef PubMed
  21.Song SJ, Sohn JH, Park KH. Evaluation of the efficacy of vitrectomy for persistent diabetic macular edema and associated factors predicting outcome. Korean J Ophthalmol. 2007;21:146鈥?0.CrossRef PubMed Central PubMed
  22.Shah SP, Patel M, Thomas D, Aldington S, Laidlaw DA. Factors predicting outcome of vitrectomy for diabetic macular oedema: results of a prospective study. Br J Ophthalmol. 2006;90:33鈥?.CrossRef PubMed Central PubMed
  23.Yamada Y, Suzuma K, Kumagami T, Fujikawa A, Kitaoka T. Systemic factors influence the prognosis of diabetic macular edema after pars plana vitrectomy with internal limiting membrane peeling. Ophthalmologica. 2013;229:142鈥?.CrossRef PubMed
  24.Jonas JB, Martus P, Degenring RF, Kreissig I, Akkoyun I. Predictive factors for visual acuity after intravitreal triamcinolone treatment for diabetic macular edema. Arch Ophthalmol. 2005;123:1338鈥?3.CrossRef PubMed
  25.Chung EJ, Roh MI, Kwon OW, Koh HJ. Effects of macular ischemia on the outcome of intravitreal bevacizumab therapy for diabetic macular edema. Retina. 2008;28:957鈥?3.CrossRef PubMed
  26.Ibrahim MA, Sepah YJ, Symons RC, Channa R, Hatef E, Khwaja A, et al. Spectral- and time-domain optical coherence tomography measurements of macular thickness in normal eyes and in eyes with diabetic macular edema. Eye (Lond). 2012;26:454鈥?2.CrossRef
  27.Krebs I, Hagen S, Smretschnig E, Womastek I, Brannath W, Binder S. Conversion of Stratus optical coherence tomography (OCT) retinal thickness to Cirrus OCT values in age-related macular degeneration. Br J Ophthalmol. 2011;95:1552鈥?.CrossRef PubMed
  28.Bengtsson B, Krakau CE. Some essential optical features of the Zeiss fundus camera. Acta Ophthalmol (Copenh). 1977;55:123鈥?1.CrossRef
  29.Conrath J, Giorgi R, Raccah D, Ridings B. Foveal avascular zone in diabetic retinopathy: quantitative vs qualitative assessment. Eye (Lond). 2005;19:322鈥?.CrossRef
  30.Bresnick GH. Diabetic maculopathy: a critical review highlighting diffuse macular edema. Ophthalmology. 1983;90:1301鈥?7.CrossRef PubMed
  31.Weiter JJ, Zuckerman R. The influence of photoreceptor-RPE complex on the inner retina; an explanation for beneficial effects of photocoagulation. Ophthalmology. 1980;87:1133鈥?.CrossRef PubMed
  32.Wallow IH. Repair of the pigment epithelial barrier following photocoagulation. Arch Ophthalmol. 1984;102:126鈥?5.CrossRef PubMed
  33.Arend O, Wolf S, Jung F, Bertram B, Postgens H, Toonen H, et al. Retinal microcirculation in patients with diabetes mellitus: dynamic and morphological analysis of perifoveal capillary network. Br J Ophthalmol. 1991;75:514鈥?.CrossRef PubMed Central PubMed
  34.Bresnick GH, Condit R, Syrjala S, Palta M, Groo A, Korth K. Abnormalities of the foveal avascular zone in diabetic retinopathy. Arch Ophthalmol. 1984;102:1286鈥?3.CrossRef PubMed
  35.Early Treatment Diabetic Retinopathy Study Research Group. Classification of diabetic retinopathy from fluorescein angiograms ETDRS report number 11. Ophthalmology. 1991;98:807鈥?2.CrossRef
  36.Sim DA, Keane PA, Zarranz-Ventura J, Fung S, Powner MB, Platteau E, et al. The effects of macular ischemia on visual acuity in diabetic retinopathy. Invest Ophthalmol Vis Sci. 2013;54:2353鈥?0.CrossRef PubMed
  37.Sakata K, Funatsu H, Harino S, Noma H, Hori S. Relationship between macular microcirculation and progression of diabetic macular edema. Ophthalmology. 2006;113:1385鈥?1.CrossRef PubMed
  38.Kimura T, Kiryu J, Nishiwaki H, Oh H, Suzuma K, Watanabe D, et al. Efficacy of surgical removal of the internal limiting membrane in diabetic cystoid macular edema. Retina. 2005;25:454鈥?1.CrossRef PubMed
  39.Lewis H, Abrams GW, Blumenkranz MS, Campo RV. Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology. 1992;99:753鈥?.CrossRef PubMed
  40.Stefansson E. The therapeutic effects of retinal laser treatment and vitrectomy. a theory based on oxygen and vascular physiology. Acta Ophthalmol Scand. 2001;79:435鈥?0.CrossRef PubMed
  41.Funatsu H, Yamashita H, Ikeda T, Mimura T, Shimizu E, Hori S. Relation of diabetic macular edema to cytokines and posterior vitreous detachment. Am J Ophthalmol. 2003;135:321鈥?.CrossRef PubMed
  42.Otani T, Kishi S. A controlled study of vitrectomy for diabetic macular edema. Am J Ophthalmol. 2002;134:214鈥?.CrossRef PubMed
  
• 作者单位：Jaeryung Kim (1) (2)
  Se Woong Kang (2)
  Dong Hoon Shin (2)
  Sang Jin Kim (2)
  Ga Eun Cho (2)
  
  1. The Laboratory of Vascular Biology and Stem Cells, Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea
  2. Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, #50 Irwon-dong, Kangnam-gu, Seoul, 135-710, Republic of Korea
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Ophthalmology
  
• 出版者：Springer Japan
• ISSN：1613-2246

文摘

Purpose To investigate the effect of vitrectomy on the treatment of diabetic macular edema (DME) refractory to nonsurgical therapies and to determine the preoperative prognostic factors related to surgical outcomes.